Utama › Mieloma Pelbagai › New Hampshire
Kajian klinikal Mieloma Pelbagai di New Hampshire
4 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi di New Hampshire.
Teks kajian rasmi (Bahasa Inggeris)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Dartmouth Hitchcock Medical Center, Lebanon
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05552222TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NH Oncology - Hematology, PA, Concord
- Solinsky Center for Cancer Care, Manchester
- New England Cancer Specialist, Portsmouth
Mengambil pesertaFasa 2
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02693535A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
- Dartmouth-Hitchcock Medical Center, Lebanon
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07280013Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Exeter Hospital, Exeter
Mengambil pesertaFasa 3
Semua umur · Semua jantina · Dikemas kini 10 Jun 2026 · NCT05561387Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.